Mouse embryonic stem cells induce targeted DNA demethylation within human MAGE-A1 transgenes

Epigenetics

Volumn 3, Issue 1, 2008, Pages 38-42

  Loriot, Axelle ^a   Sterpin, Christiane ^b   De Backer, Olivier ^b   De Smet, Charles ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Cancer germline genes; Cancer testis genes; DNA hypomethylation; DNA methylation; Embryonic stem cells; Epigenetics; MAGE A1

Indexed keywords

DNA; MELANOMA ANTIGEN 1;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PROMOTER REGION;

EID: 42149108433     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.3.1.5411     Document Type: Article

References (17)

1. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6-21.
2. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293:1089-93.
3. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 1998; 72:141-96.
4. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300:489-92.
5. De Smet C, Lurquin C, Lethé B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999; 19:7327-35.
6. Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Muntefering H, Huber C, Sahin U, Tureci O. Frequent nonrandom activation of germ-line genes in human cancer. Cancer Res 2004; 64:5988-93.
7. De Smet C, Loriot A, Boon T. Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells. Mol Cell Biol 2004; 24:4781-90.
8. Loriot A, De Plaen E, Boon T, De Smet C. Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells. J Biol Chem 2006; 281:10118-26.
9. Frank D, Keshet I, Shani M, Levine A, Razin A, Cedar H. Demethylation of CpG islands in embryonic cells. Nature 1991; 351:239-41.
10. Hertz JM, Schell G, Doerfler W. Factors affecting de novo methylation of foreign DNA in mouse embryonic stem cells. J Biol Chem 1999; 274:24232-40.
11. Jacobs JF, Brasseur F, Hulsbergen-van de Kaa CA, van de Rakt MW, Figdor CG, Adema GJ, Hoogerbrugge PM, Coulie PG, de Vries IJ. Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR. Int J Cancer 2007; 120:67-74.
12. Kurosawa H, Imamura T, Koike M, Sasaki K, Amano Y. A simple method for forming embryoid body from mouse embryonic stem cells. J Biosci Bioeng 2003; 96:409-11.
13. Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C. Expression of BORIS in melanoma: Lack of association with MAGE-A1 activation. Int J Cancer 2007; 15122: 777-84
14. De Smet C, Courtois SJ, Faraoni I, Lurquin C, Szikora JP, De Backer O, Boon T. Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics 1995; 42:282-90.
15. Shiota K, Kogo Y, Ohgane J, Imamura T, Urano A, Nishino K, Tanaka S, Hattori N. Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells 2002; 7:961-9.
16. Boyes J, Bird A. Repression of genes by DNA methylation depends on CpG density and promoter strength: Evidence for involvement of a methyl-CpG binding protein. Embo J 1992; 11:327-33.
17. Muiznieks I, Doerfler W. The impact of 5'-CG-3' methylation on the activity of different eukaryotic promoters: A comparative study. FEBS Lett 1994; 344:251-4.